Annual Revenue
$192.64 M
-$61.74 M-24.27%
31 December 2023
Summary:
Vanda Pharmaceuticals annual revenue is currently $192.64 million, with the most recent change of -$61.74 million (-24.27%) on 31 December 2023. During the last 3 years, it has fallen by -$55.53 million (-22.38%). VNDA annual revenue is now -28.30% below its all-time high of $268.68 million, reached on 31 December 2021.VNDA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$47.65 M
-$2.82 M-5.59%
30 September 2024
Summary:
Vanda Pharmaceuticals quarterly revenue is currently $47.65 million, with the most recent change of -$2.82 million (-5.59%) on 30 September 2024. Over the past year, it has increased by +$8.84 million (+22.76%). VNDA quarterly revenue is now -32.02% below its all-time high of $70.09 million, reached on 30 September 2021.VNDA Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$190.86 M
+$8.84 M+4.85%
30 September 2024
Summary:
Vanda Pharmaceuticals TTM revenue is currently $190.86 million, with the most recent change of +$8.84 million (+4.85%) on 30 September 2024. Over the past year, it has dropped by -$20.99 million (-9.91%). VNDA TTM revenue is now -28.97% below its all-time high of $268.68 million, reached on 31 December 2021.VNDA TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VNDA Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.3% | +22.8% | -9.9% |
| 3 y3 years | -22.4% | -32.0% | -28.9% |
| 5 y5 years | -0.3% | -19.9% | -13.0% |
VNDA Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -28.3% | at low | -32.0% | +22.8% | -29.0% | +7.5% |
| 5 y | 5 years | -28.3% | at low | -32.0% | +22.8% | -29.0% | +7.5% |
| alltime | all time | -28.3% | >+9999.0% | -32.0% | +947.7% | -29.0% | +4096.5% |
Vanda Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $47.65 M(-5.6%) | $190.86 M(+4.9%) |
| June 2024 | - | $50.47 M(+6.3%) | $182.02 M(+2.5%) |
| Mar 2024 | - | $47.46 M(+4.8%) | $177.60 M(-7.8%) |
| Dec 2023 | $192.64 M(-24.3%) | $45.27 M(+16.6%) | $192.64 M(-9.1%) |
| Sept 2023 | - | $38.81 M(-15.7%) | $211.85 M(-11.1%) |
| June 2023 | - | $46.06 M(-26.3%) | $238.35 M(-7.1%) |
| Mar 2023 | - | $62.50 M(-3.1%) | $256.69 M(+0.9%) |
| Dec 2022 | $254.38 M(-5.3%) | $64.48 M(-1.3%) | $254.38 M(-1.4%) |
| Sept 2022 | - | $65.32 M(+1.4%) | $257.92 M(-1.8%) |
| June 2022 | - | $64.39 M(+7.0%) | $262.70 M(-1.3%) |
| Mar 2022 | - | $60.19 M(-11.5%) | $266.20 M(-0.9%) |
| Dec 2021 | $268.68 M(+8.3%) | $68.02 M(-3.0%) | $268.68 M(+0.1%) |
| Sept 2021 | - | $70.09 M(+3.2%) | $268.32 M(+3.8%) |
| June 2021 | - | $67.90 M(+8.3%) | $258.53 M(+2.3%) |
| Mar 2021 | - | $62.67 M(-7.4%) | $252.84 M(+1.9%) |
| Dec 2020 | $248.17 M(+9.2%) | $67.65 M(+12.2%) | $248.17 M(+2.8%) |
| Sept 2020 | - | $60.31 M(-3.1%) | $241.44 M(+0.3%) |
| June 2020 | - | $62.21 M(+7.3%) | $240.62 M(+1.3%) |
| Mar 2020 | - | $58.00 M(-4.8%) | $237.47 M(+4.5%) |
| Dec 2019 | $227.19 M(+17.6%) | $60.93 M(+2.4%) | $227.19 M(+3.6%) |
| Sept 2019 | - | $59.48 M(+0.7%) | $219.30 M(+5.0%) |
| June 2019 | - | $59.06 M(+23.8%) | $208.95 M(+5.9%) |
| Mar 2019 | - | $47.71 M(-10.0%) | $197.24 M(+2.1%) |
| Dec 2018 | $193.12 M(+17.0%) | $53.04 M(+7.9%) | $193.12 M(+4.8%) |
| Sept 2018 | - | $49.13 M(+3.8%) | $184.35 M(+4.4%) |
| June 2018 | - | $47.35 M(+8.6%) | $176.55 M(+3.1%) |
| Mar 2018 | - | $43.59 M(-1.5%) | $171.26 M(+3.7%) |
| Dec 2017 | $165.08 M | $44.28 M(+7.1%) | $165.08 M(+3.8%) |
| Sept 2017 | - | $41.34 M(-1.7%) | $159.05 M(+1.8%) |
| June 2017 | - | $42.06 M(+12.4%) | $156.20 M(+4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $37.41 M(-2.2%) | $150.17 M(+2.8%) |
| Dec 2016 | $146.02 M(+32.8%) | $38.24 M(-0.6%) | $146.02 M(+4.6%) |
| Sept 2016 | - | $38.48 M(+6.8%) | $139.62 M(+7.8%) |
| June 2016 | - | $36.03 M(+8.3%) | $129.48 M(+7.0%) |
| Mar 2016 | - | $33.26 M(+4.4%) | $121.04 M(+10.1%) |
| Dec 2015 | $109.92 M(+119.2%) | $31.85 M(+12.4%) | $109.92 M(+17.6%) |
| Sept 2015 | - | $28.34 M(+2.8%) | $93.44 M(+17.0%) |
| June 2015 | - | $27.58 M(+24.5%) | $79.88 M(+26.5%) |
| Mar 2015 | - | $22.15 M(+44.1%) | $63.16 M(+25.9%) |
| Dec 2014 | $50.16 M(+48.0%) | $15.37 M(+4.0%) | $50.16 M(+15.1%) |
| Sept 2014 | - | $14.78 M(+36.1%) | $43.57 M(+16.2%) |
| June 2014 | - | $10.86 M(+18.8%) | $37.50 M(+7.3%) |
| Mar 2014 | - | $9.14 M(+4.1%) | $34.95 M(+3.2%) |
| Dec 2013 | $33.88 M(+3.5%) | $8.78 M(+0.8%) | $33.88 M(+2.6%) |
| Sept 2013 | - | $8.71 M(+4.7%) | $33.02 M(+1.3%) |
| June 2013 | - | $8.32 M(+3.1%) | $32.59 M(-0.2%) |
| Mar 2013 | - | $8.07 M(+1.9%) | $32.65 M(-0.2%) |
| Dec 2012 | $32.73 M(+4.7%) | $7.92 M(-4.4%) | $32.73 M(-1.4%) |
| Sept 2012 | - | $8.29 M(-1.1%) | $33.18 M(+1.0%) |
| June 2012 | - | $8.38 M(+2.9%) | $32.86 M(+3.0%) |
| Mar 2012 | - | $8.14 M(-2.7%) | $31.91 M(+2.0%) |
| Dec 2011 | $31.27 M(-11.2%) | $8.37 M(+5.0%) | $31.27 M(+3.7%) |
| Sept 2011 | - | $7.97 M(+7.3%) | $30.16 M(+2.5%) |
| June 2011 | - | $7.43 M(-0.9%) | $29.44 M(-2.8%) |
| Mar 2011 | - | $7.50 M(+3.3%) | $30.30 M(-14.0%) |
| Dec 2010 | $35.22 M(+674.4%) | $7.26 M(+0.2%) | $35.22 M(+8.4%) |
| Sept 2010 | - | $7.25 M(-12.6%) | $32.51 M(+28.7%) |
| June 2010 | - | $8.29 M(-33.3%) | $25.26 M(+48.9%) |
| Mar 2010 | - | $12.42 M(+173.1%) | $16.97 M(+273.1%) |
| Dec 2009 | $4.55 M(>+9900.0%) | $4.55 M | $4.55 M |
| Dec 2004 | $34.00 K | - | - |
FAQ
- What is Vanda Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals annual revenue year-on-year change?
- What is Vanda Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals quarterly revenue year-on-year change?
- What is Vanda Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals TTM revenue year-on-year change?
What is Vanda Pharmaceuticals annual revenue?
The current annual revenue of VNDA is $192.64 M
What is the all time high annual revenue for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high annual revenue is $268.68 M
What is Vanda Pharmaceuticals annual revenue year-on-year change?
Over the past year, VNDA annual revenue has changed by -$61.74 M (-24.27%)
What is Vanda Pharmaceuticals quarterly revenue?
The current quarterly revenue of VNDA is $47.65 M
What is the all time high quarterly revenue for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high quarterly revenue is $70.09 M
What is Vanda Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, VNDA quarterly revenue has changed by +$8.84 M (+22.76%)
What is Vanda Pharmaceuticals TTM revenue?
The current TTM revenue of VNDA is $190.86 M
What is the all time high TTM revenue for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high TTM revenue is $268.68 M
What is Vanda Pharmaceuticals TTM revenue year-on-year change?
Over the past year, VNDA TTM revenue has changed by -$20.99 M (-9.91%)